Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Messenger RNA-Based Therapeutics and Vaccines: What’s beyond COVID-19?
Dongqiao Li, Cynthia Liu, Yingzhu Li, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 943-969
Open Access | Times Cited: 24

Showing 24 citing articles:

Strategies to reduce the risks of mRNA drug and vaccine toxicity
Dimitrios Bitounis, Eric Jacquinet, Maximillian A. Rogers, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 281-300
Closed Access | Times Cited: 59
COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
Aleksandra Anna Zasada, Aniela Darlińska, Aldona Wiatrzyk, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1786-1786
Open Access | Times Cited: 22
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery
Rumiana Koynova, Kevin J. Hughes, Magesh Ganesan, et al.
ACS Nano (2025)
Open Access | Times Cited: 1
Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines
Li Zhang, Brandon Yi Loong Seow, K Ba, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 108-124
Closed Access | Times Cited: 1
Recent advances in mRNA‐based vaccine for cancer therapy; bench to bedside
Hadeel Ahmed Kenoosh, Harikumar Pallathadka, Ahmed Hjazi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 5
RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
The Bright Future of mRNA as a Therapeutic Molecule
Dora Emma Vélez, Blanca Licia Torres, Greco Hernández
Genes (2025) Vol. 16, Iss. 4, pp. 376-376
Open Access
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 528-528
Open Access | Times Cited: 4
Polysarcosine functionalised cationic polyesters efficiently deliver self-amplifying mRNA
Hulya Bayraktutan, Rafał J. Kopiasz, Amr Elsherbeny, et al.
Polymer Chemistry (2024) Vol. 15, Iss. 18, pp. 1862-1876
Open Access | Times Cited: 3
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
(2024)
Open Access | Times Cited: 3
Toward a large-batch manufacturing process for silicon-stabilized lipid nanoparticles: A highly customizable RNA delivery platform
Suzanne Saffie-Siebert, Nissim Torabi-Pour, Andrew Gibson, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101299-101299
Open Access | Times Cited: 3
The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
Karol Kurpiejewski, Anna Stankiewicz-Drogoń, Karolina Piecyk, et al.
Frontiers in Molecular Biosciences (2024) Vol. 10
Open Access | Times Cited: 1
Lipid nanoparticles-based RNA therapies for breast cancer treatment
Luigia Serpico, Yuewen Zhu, Renata Faria Maia, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2823-2844
Open Access | Times Cited: 1
Unlocking the Gates: Therapeutic Agents for Noninvasive Drug Delivery Across the Blood-Brain Barrier
Courtney Culkins, Roman Adomanis, Nathan Phan, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 1
LNP-mRNA delivers TNF-α antibody to deep cartilage and protects against osteoarthritis
Baixing Li, Lei Cui, Keyu Kong, et al.
Chemical Engineering Journal (2024) Vol. 500, pp. 156723-156723
Closed Access | Times Cited: 1
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells
Matteo Zurlo, Jessica Gasparello, Marco Verona, et al.
Experimental Cell Research (2023) Vol. 433, Iss. 2, pp. 113853-113853
Open Access | Times Cited: 2
Chemistry and democracy: a symbiotic relationship
Carina I. C. Crucho
Trends in Chemistry (2024) Vol. 6, Iss. 2, pp. 51-54
Closed Access
Vacinas de RNA mensageiro: da Revolução tecnológica à eficácia no controle da pandemia de COVID-19
Ellen Cristina Silva, Daniela Santos Pontes
(2024), pp. 1-13
Open Access
Identification of colon adenocarcinoma necroptosis subtypes and tumor antigens for the development of mRNA vaccines
Yuqi Luo, Caijie Lu, Yi‐Wen Huang, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32531-e32531
Open Access
Isosteric 3D Bicyclo[1.1.1]Pentane (BCP) Core-Based Lipids for mRNA Delivery and CRISPR/Cas Gene Editing
Shiying Wu, Yangyang Yang, Xizhen Lian, et al.
Journal of the American Chemical Society (2024)
Closed Access
Vaccine detox in Brazil: Myths and risks of a pseudoscientific therapy
Heslley Machado Silva
The American Journal of the Medical Sciences (2023)
Closed Access | Times Cited: 1
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells
Matteo Zurlo, Jessica Gasparello, Marco Verona, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
La technologie de l’ARN messager
Nabila Laroui, Chantal Pichon
Actualités Pharmaceutiques (2023) Vol. 62, Iss. 629, pp. S6-S10
Closed Access
Page 1

Scroll to top